Showing stories 1 - 10 of about 16
ARK THERAPEUTICS GROUP PLC : - Interim Management Statement
17 May 2013 - Ark Therapeutics Group plc ("Ark" or the "Company") today publishes its interim management statement for the period from 1 January 2013 to date.
Related articles »
ARK THERAPEUTICS GROUP PLC : - Final Results
Ark Therapeutics Group plc. Preliminary Announcement - Final results for the year ended 31 December 2012. London, UK, 30 April 2013- Ark Therapeutics Group plc (LSE: AKT) today announces its audited results for the year ended 31 December 2012.
Related articles »
PURICORE PLC : Board Changes
Mr Spicer is a Non-Executive Director of Aircraft Medical, Stanmore Implants, Ark Therapeutics Group plc, and XCounter AB. He is chair of the UK Department of Health's Invention for Innovation Funding Panel, a panel member on the UK Health Innovation ...
DIARY - Western European Corporate events from May 17
... 17-May GB ARK THERAPEUTICS GROUP PLC Q1 TRADE 17-May GB ALENT PLC Q1 TRADE 17-May GB ALPHA PYRENEES TRUST LTD Q1 TRADE 17-May GB BRAMMER PLC TRADING 17-May GB 6:00 CHESNARA PLC Q1 TRADE 17-May DE ...
Related articles »
DIARY - Western European Corporate events from May 15
... 17-May GB ARK THERAPEUTICS GROUP PLC Q1 TRADE 17-May GB ALENT PLC Q1 TRADE 17-May GB ALPHA PYRENEES TRUST LTD Q1 TRADE 17-May GB BRAMMER PLC TRADING 17-May GB CENTAUR MEDIA PLC TRADING 17-May GB 6:00 ...
Related articles »
Pharmaceutical Market: Finland, Ireland, Denmark, Belgium, Cuba, Austria ...
... followed by Pfizer, Novartis, AstraZeneca and GlaxoSmithKline. In the biologic sector, Biotie Therapies completed its acquisition of Synosia Therapeutics in February 2011, while Ark Therapeutics entered into a formal agreement to divest the ...
Related articles »